… ATP-competitive inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
(SB-216763) 9 was used as a positive control … The results are summarized in Table 3. …

… The SB216763 group received intraperitoneal injections of SB216763 (0.6 mg/kg) for 3 days,
… -(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763) is a partial agonist of the aryl …

… A frequently used inhibitor of glycogen synthase kinase (GSK), SB216763 (V-10), which
is structurally 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, was …

… SB-216763 (3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione) was
purchased from Axon Medchem. RPMI medium 1640, Dulbecco’s modified Eagle’s medium, …

… -3 inhibitors SB216763 (3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione)
and AR-A014418 (N-[(4-Methoxyphenyl)methyl]-N′-(5-nitro-2-thiazolyl)urea) were …

… glycogen synthase kinase-3 (GSK-3) inhibitors (SB216763 and … 3 inhibitors SB216763
(3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione) and AR-A014418 (N-[(4…

Recent studies have provided evidence that triiodothyronine (T3) might play an effective role
in the recovery of ischemic myocardium, through the preservation of mitochondrial function …

… Glycogen synthase kinase 3 (GSK3) signals downstream of mGluR 5 and upstream of
FMRP, and its activation affects all major hallmarks of Alzheimer’s disease and FXS (Figure 1). …

… in the TDZD-8 groups were greater than those in the SB216763 groups. … glycogen synthase
kinase-3 (GSK-3) activity contributes to the pathological processes of COPD. Citation4 GSK3 …

… 1 (DKK1) or niclosamide, glycogen kinase-3 beta (GSK-3β) using SB-216763, cyclic-AMP …
SB-216763 (3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione) is a …